Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 N-of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?

Literature DB >> 30887430

N-of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?

Richard L Kravitz¹.

Abstract

Entities: Disease

Year: 2019 PMID： 30887430 PMCID： PMC6544726 DOI： 10.1007/s11606-019-04938-3

Source DB: PubMed Journal: J Gen Intern Med ISSN： 0884-8734 Impact factor: 5.128

Keyword Cloud
References

× No keyword cloud information.

13 in total

1. Delusions of success. How optimism undermines executives' decisions.

Authors: Dan Lovallo; Daniel Kahneman
Journal: Harv Bus Rev Date: 2003-07

2. Deaths preventable in the U.S. by improvements in use of clinical preventive services.

Authors: Thomas A Farley; Mehul A Dalal; Farzad Mostashari; Thomas R Frieden
Journal: Am J Prev Med Date: 2010-06 Impact factor: 5.043

3. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.

Authors: Deborah R Zucker; Robin Ruthazer; Christopher H Schmid; Jacqueline M Feuer; Peter A Fischer; Raphael I Kieval; Nicola Mogavero; Ronald J Rapoport; Harry P Selker; Sharon A Stotsky; Eileen Winston; Don L Goldenberg
Journal: J Rheumatol Date: 2006-10 Impact factor: 4.666

Review 4. Variability in response to antihypertensive drugs.

Authors: Barry J Materson
Journal: Am J Med Date: 2007-04 Impact factor: 4.965

5. Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Authors: Sanket S Dhruva; Chenxi Huang; Erica S Spatz; Andreas C Coppi; Frederick Warner; Shu-Xia Li; Haiqun Lin; Xiao Xu; Curt D Furberg; Barry R Davis; Sara L Pressel; Ronald R Coifman; Harlan M Krumholz
Journal: Hypertension Date: 2017-05-30 Impact factor: 10.190

Review 10. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research.

Authors: Naihua Duan; Richard L Kravitz; Christopher H Schmid
Journal: J Clin Epidemiol Date: 2013-08 Impact factor: 6.437

N-of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?

1. Delusions of success. How optimism undermines executives' decisions.

2. Deaths preventable in the U.S. by improvements in use of clinical preventive services.

3. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.

Review 4. Variability in response to antihypertensive drugs.

5. Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Review 6. N-of-1 trials in the medical literature: a systematic review.

7. Marketing therapeutic precision: Potential facilitators and barriers to adoption of n-of-1 trials.

8. Determining optimal therapy--randomized trials in individual patients.

9. What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future.

Review 10. Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research.